Navigation Links
Accelr8 to Hold 2012 Annual Meeting of Shareholders; Product Development Continues with Launch Expected in 2015
Date:12/11/2012

DENVER, Dec. 11, 2012 /PRNewswire/ -- Accelr8 Technology Corporation (NYSE MKT: AXK) will hold its 2012 Annual Meeting of Shareholders (the "Annual Meeting") at 2:30 p.m., local time, on Wednesday, December 12, 2012, at the Warwick Hotel Denver, 1776 Grant Street, Denver, Colorado 80203.

Progress towards the company's IVD product launch continues, with management expecting to be in development through 2014, launching in 2015, with additional clinical trials continuing through 2016.

About Accelr8

Accelr8 Technology Corporation (www.accelr8.com) is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.  The Company's BACcel™ platform utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies that decrease time to result while maintaining high sensitivity and specificity. 

Disclaimer Regarding Forward-Looking Statements

Certain statements in this news release may be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Statements regarding future prospects and developments are based upon current expectations and involve certain risks and uncertainties that could cause actual results and developments to differ materially from the forward-looking statement, including those detailed in the Company's filings with the SEC.  The Company does not undertake an obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events.


'/>"/>
SOURCE Accelr8 Technology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Accelr8 Appoints Steve Reichling Chief Financial Officer
2. MiMedx Group to Present at the 6th Annual OneMedForum
3. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
6. Thoratec Presentation At Oppenheimer 23rd Annual Healthcare Conference To Be Webcast
7. Henry Schein To Present At The Oppenheimer 23rd Annual Healthcare Conference
8. PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
9. Accuray Incorporated to Speak at 23rd Annual Oppenheimer Healthcare Conference
10. HeartWare Presentation at the Oppenheimer 23rd Annual Healthcare Conference to be Webcast
11. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... 11, 2014 Research and Markets ... the "Drug Injection Devices to 2020" ... http://photos.prnewswire.com/prnh/20130307/600769 As new drugs ... list of health conditions, drug developers have increasingly ... administration process and increase the efficiency and reliability ...
(Date:12/13/2014)... , Dec. 12, 2014 HudsonAlpha ... the HiSeq X Ten sequencing system manufactured by ... HudsonAlpha to produce and analyze genomic data faster ... from the Institute,s commitment to research programs for ... HiSeq X Ten provides unprecedented capacity, speed and ...
(Date:12/13/2014)... and INDIANAPOLIS , Dec. 12, 2014 ... Chip Ganassi Racing Teams (CGRT), today announced a multi-year extension ... primary sponsor of the No. 83 Novo Nordisk Chip Ganassi ... Verizon IndyCar Series. Kimball, 29, from ... licensed driver with diabetes in the history of INDYCAR to ...
Breaking Medicine Technology:Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 2Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 4Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 5Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 6Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 7
... 25, 2011 An interesting statistic: more than half (55%) ... having a hair transplant if celebrities or public figures were ... likely to be influenced than women (57% vs. 45%). ... have openly admitted to hair restoration, including Kevin Costner, Mel ...
... Wash., Jan. 24, 2011 Cardiac Science Corporation ... AED ) and diagnostic cardiac monitoring devices, ... Army,s Research, Development, and Engineering Command for the ... indicates the Powerheart AED G3 Pro complies with U.S. ...
Cached Medicine Technology:More and More Celebrities Are Embracing Hair Restoration 2Cardiac Science Awarded US Military Certification 2Cardiac Science Awarded US Military Certification 3Cardiac Science Awarded US Military Certification 4
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... holiday party season fast approaching, a new study reveals that ... arrests have fewer drunk drivers on their roads. The ... vigilantly are better able to deter inebriated revelers from getting ... new laws are being passed regarding drinking and driving," said ...
(Date:12/15/2014)... December 15, 2014 Veretekk.com, Inc. announced ... Ocean Avenue. JM Ocean Avenue has secured exclusive ... online automated marketing system. JM Ocean Avenue is ... merger of Ocean Avenue and JM International, with partial ... Billion per year company. , “After nearly 2 decades ...
(Date:12/15/2014)... Health Dialog, a leading provider of ... has received Patient Oriented Accreditation from the National ... Management (DM) Programs for asthma, congestive heart failure, ... and diabetes. This marks the 12th continuous year ... Management (DM) Programs, reaffirming Health Dialog’s focus and ...
(Date:12/15/2014)... December 15, 2014 Emergo Group, Inc., ... 26 countries in North and South America, Europe, the ... from industry participants for its 2015 Medical Device Industry ... to identify upcoming business and market trends as well ... The survey targets areas including:, , ...
(Date:12/15/2014)... 15, 2014 For the second year in ... “Top 30 Coffees of 2014.” Bird Rock Coffee Roasters’ Sumatra ... Zone Ethiopia at number 10. This is the first year ... Review’s selection is ranked on quality, value, and other aspects, ... 96 out of 100, and at $17.99 for 12-ounces, was ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2
... New Data Shows a Comprehensive Technology Infrastructure Improves ... Calif., March 10 Two Kaiser Permanente studies ... that a comprehensive electronic health record can increase ... maintaining clinical quality and that connecting patients directly ...
... Medical Solutions recently completed the first 1,000 ... Scorpion Offshore Inc.,s ultra-premium jackup rig, Offshore ... Offshore the first drilling contractor to provide ... advanced healthcare, direct physician attention and improved ...
... new Autism specialistsCALDWELL, N.J., March 10 Caldwell College ... Innovations in Autism Treatment and Applied Behavior Analysis ... from 8:45 a.m. to 5:15 p.m. Widely recognized leaders in the ... science based approach to learning , will speak at the ...
... 10 /PRNewswire-Asia/ -- Obio Pharmaceutical Holdings Ltd,("Obio"/ "the Company") ... drug,TG21, against main strains of influenza virus (including avian ... process leading to clinical,trials for TG21 has already commenced. ... continue to engage prestigious institutions in USA and,China to ...
... are the two leading causes of chronic kidney disease, and during ... ensure that individuals have the information they need to take charge ... ... 10-- Diabetes and high blood pressure are the two leading causes ...
... has today announced that Guy,s and St Thomas, ... of the BigHand digital dictation workflow system, further ... patient care across a number of specialties. The ... award winning BigHand system within Oncology and Renal ...
Cached Medicine News:Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 2Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 3Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 4Health News:Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services 2Health News:Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services 3Health News:Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month 2Health News:Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month 3Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 2Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 3Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 2Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 3Health News:Guy's and St Thomas' NHS Foundation Trust extends patient care benefits of BigHand Digital Dictation 2
... Throughput Sorter RSD ProVolume ... in the field of pre-sorting and ... of considerable speed but is also ... can be integrated. Secure and tight ...
... System RCS 800 closes various plastic primary and ... way. Different tube heights and diameters can be ... be used for send-outs. The integration into other ... System RSD 800 and High Throughput Sorter RSD ...
... DS 800 selectively removes closures from various sample ... towards the rack opening in one run. The ... PVT Systems like Sorting System RS 800 (optional), ... ProVolume and Aliquoting System RSD 800A. All common ...
... offers reagents to detect sequences of ... virus 1, 2 and 3; influenza ... syncytial virus A and B. ... create homebrew tests., *Analyte ...
Medicine Products: